Martek Biosciences Corp. – Aggressive Growth – Zacks Rank Buy
Zacks Market Commentaries (October 19th, 2008) Writes:
Martek Bioscience (MATK) announced in September that made it a multiple license and supply deal with an international food companies, Hero, Grupo Ricap, and Hochdorf Nutricare. Martek will supply all of companies' ARA and DHA for infant formula and children's food and milk, specially designed for a child's early life.
The deal allows Martek to continue its international expansion into Mexico, Europe, and China. Martek's proprietary DHA and ARA blend is used in approximately 95% of infant formulas sold in the U.S.
On Sep 4 Martek announced third-quarter earnings that included earnings per share of 28 cents. This market the fourth surprise in the past 4 quarters, as analysts were only expecting 24 cents. Revenues rose 14% year-over-year to $88.4 million.
Martek also raised full-year guidance during the announcement. The company expects earnings per share to be between $1.06 and $1.09,
...Tags for this Post:
beauty retailer, cents, China, Cosmetics & Fragrance Inc., Europe, food, Grupo Ricap, Hero, Hochdorf Nutricare, Martek Biosciences Corp, Mexico, Perrigo Company, Revlon Inc., Stocks to Watch, United States, USD, Zhongpin Inc.
beauty retailer, cents, China, Cosmetics & Fragrance Inc., Europe, food, Grupo Ricap, Hero, Hochdorf Nutricare, Martek Biosciences Corp, Mexico, Perrigo Company, Revlon Inc., Stocks to Watch, United States, USD, Zhongpin Inc.


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
